Vascular tissue engineering - Biomaterials and Devices for the Circulatory System - page 347

KATAOKA, H., TAKAKURA, N., NISHIKAWA, S., TSUCHIDA, K., KODAMA, H., KUNISADA, T.,
RISAU, W., KITA, T., and NISHIKAWA, S.I. (1997). Expressions of PDGF receptor
alpha, c-Kit and Flk1 genes clustering in mouse chromosome 5 defi ne distinct
subsets of nascent mesodermal cells. Development, Growth & Differentiation 39 ,
729-740.
KATTMAN, S.J., HUBER, T.L., and KELLER, G.M. (2006). Multipotent fl k-1 cardiovascular

progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth
muscle lineages. Developmental Cell 11 , 723-732.
KETCHEDJIAN, A., JONES, A.L., KRUEGER, P. , ROBINSON, E., CROUCH, K., WOLFI NBARGER,
L., JR., and HOPKINS, R. (2005). Recellularization of decellularized allograft scaf-
folds in ovine great vessel reconstructions. Ann Thorac Surg 79 , 888-896; discus-
sion 896.
KIDOAKI, S., KWON, I.K., and MATSUDA, T. (2005). Mesoscopic spatial designs of nano-
and microfi ber meshes for tissue-engineering matrix and scaffold based on newly
devised multilayering and mixing electrospinning techniques. Biomaterials 26 ,
37-46.
KILLEWICH, L.A., and BARTLETT, S.T. (1990). The 'all-autogenous' tissue policy for
infrainguinal reconstruction questioned. Am J Surg 160 , 552-554; discussion
554-555.
KIM, S., and VON RECUM, H. (2008). Endothelial stem cells and precursors for tissue
engineering: cell source, differentiation, selection, and application. Tissue Eng 14 ,
133-147.
KITO, H., and MATSUDA, T. (1996). Biocompatible coatings for luminal and outer
surfaces of small-caliber artifi cial grafts. J Biomed Mater Res 30 , 321-330.
KLEMENT, P. , DU, Y. J. , BERRY, L., ANDREW, M., and CHAN, A.K. (2002). Blood-compatible
biomaterials by surface coating with a novel antithrombin-heparin covalent
complex. Biomaterials 23 , 527-535.
KLINKERT, P. , SCHEPERS, A., BURGER, D.H., VAN BOCKEL, J.H., and BRESLAU, P. J.
(2003). Vein versus polytetrafl uoroethylene in above-knee femoropopliteal
bypass grafting: fi ve-year results of a randomized controlled trial. J Vasc Surg 37 ,
149-155.
LANGER, R., and VACANTI, J.P. (1993). Tissue engineering. Science 260 , 920-926.
LAUBE, H.R., DUWE, J., RUTSCH, W., and KONERTZ, W. (2000). Clinical experience with
autologous endothelial cell-seeded polytetrafl uoroethylene coronary artery
bypass grafts. J Thorac Cardiovasc Surg 120 , 134-141.
LEE, R.H., PULIN, A.A., SEO, M.J., KOTA, D.J., YLOSTALO, J., LARSON, B.L., SEMPRUN-PRIETO,
L., DELAFONTAINE, P. , and PROCKOP, D.J. (2009). Intravenous hMSCs improve myo-
cardial infarction in mice because cells embolized in lung are activated to secrete
the anti-infl ammatory protein TSG-6. Cell Stem Cell 5 , 54-63.
LEVENBERG, S., GOLUB, J.S., AMIT, M., ITSKOVITZ-ELDOR, J., and LANGER, R. (2002).
Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci
USA 99 , 4391-4396.
LEVENBERG, S., ZOLDAN, J., BASEVITCH, Y. , and LANGER, R. (2007). Endothelial potential
of human embryonic stem cells. Blood 110 , 806-814.
LEYH, R.G., WILHELMI, M., WALLES, T., KALLENBACH, K., REBE, P. , OBERBECK, A., HERDEN,
T., HAVERICH, A., and MERTSCHING, H. (2003). Acellularized porcine heart valve
scaffolds for heart valve tissue engineering and the risk of cross-species transmis-
sion of porcine endogenous retrovirus. J Thorac Cardiovasc Surg 126 ,
1000-1004.

+

￿ ￿ ￿ ￿ ￿